This episode of PharmTech Explained discusses how China's biotech surge is reshaping US drug licensing, manufacturing control, and FDA data trust, the key shifts pharma professionals must track.
John Stanford
Advertisement
executive director, Incubate Coalition
Articles by John Stanford
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
A Capsule-in-Capsule Platform for Multi-Phase Release of Liquid and Solid Formulations
2
Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.
3
Q&A: Sterile Injectable Manufacturers Gain New CDMO Option as Halo Expands
4
Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?
5